A new clinical trial led by the Jaeb Center for Health Research has shown that automated insulin delivery (AID) systems can significantly improve blood sugar control in adults with type 2 diabetes who ...
Experts discuss how the integration of continuous glucose monitoring (CGM) data into electronic health record (EHR) systems enhances clinical decision-making and care coordination, how primary care ...
Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Research suggests that automated insulin delivery (AID) systems may play a significant role in enhancing glucose management.
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
Also known as type 1.5 diabetes, hereās what to know about the onset, symptoms, diagnosis, and treatment options for latent ...
A real-world analysis showed a link between continuous glucose monitor (CGM) distribution channel and outcomes for patients with diabetes.
CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.
3d
Zacks Investment Research on MSNDXCM Stock Gains Following New Data on Upcoming G7 CGM SensorDexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...
With its ultra-compact design and 3-second activation, GS3 quickly became a highlight at ATTD 2025 with its revolutionary ...
Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSenseā¢, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results